Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The leading role of epithelial cells in the pathogenesis of idiopathic pulmonary fibrosis
Moisés Selman, Annie Pardo
Cellular Signalling (2019) Vol. 66, pp. 109482-109482
Closed Access | Times Cited: 179

Showing 1-25 of 179 citing articles:

Alveolar Epithelial Type II Cells as Drivers of Lung Fibrosis in Idiopathic Pulmonary Fibrosis
Tanyalak Parimon, Changfu Yao, Barry R. Stripp, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 7, pp. 2269-2269
Open Access | Times Cited: 282
Targeting PI3K/AKT signaling for treatment of idiopathic pulmonary fibrosis
Jincheng Wang, Kaili Hu, Xuanyan Cai, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 1, pp. 18-32
Open Access | Times Cited: 249
Therapeutic targets in lung tissue remodelling and fibrosis
Gang Liu, Ashleigh M. Philp, Tamera J. Corte, et al.
Pharmacology & Therapeutics (2021) Vol. 225, pp. 107839-107839
Open Access | Times Cited: 175
Clodronate-loaded liposomal and fibroblast-derived exosomal hybrid system for enhanced drug delivery to pulmonary fibrosis
Lingna Sun, Mingrui Fan, Dong Huang, et al.
Biomaterials (2021) Vol. 271, pp. 120761-120761
Closed Access | Times Cited: 123
Potential of phosphodiesterase 4B inhibition in the treatment of progressive pulmonary fibrosis
Rebecca C. Keith, Anoop M. Nambiar
Therapeutic Advances in Respiratory Disease (2025) Vol. 19
Open Access | Times Cited: 2
Macrophage-derived exosomes attenuate fibrosis in airway epithelial cells through delivery of antifibrotic miR-142-3p
Julien Guiot, Maureen Cambier, Amandine Boeckx, et al.
Thorax (2020) Vol. 75, Iss. 10, pp. 870-881
Open Access | Times Cited: 115
Traditional Chinese medicine combined with pulmonary drug delivery system and idiopathic pulmonary fibrosis: Rationale and therapeutic potential
Yukun Zhang, Peng Lü, Huan Qin, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 133, pp. 111072-111072
Open Access | Times Cited: 108
The Interplay of the Genetic Architecture, Aging, and Environmental Factors in the Pathogenesis of Idiopathic Pulmonary Fibrosis
Annie Pardo, Moisés Selman
American Journal of Respiratory Cell and Molecular Biology (2020) Vol. 64, Iss. 2, pp. 163-172
Closed Access | Times Cited: 85
Molecular Mechanisms and Cellular Contribution from Lung Fibrosis to Lung Cancer Development
Anna Valeria Samarelli, Valentina Masciale, Beatrice Aramini, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 22, pp. 12179-12179
Open Access | Times Cited: 64
When things go wrong: exploring possible mechanisms driving the progressive fibrosis phenotype in interstitial lung diseases
Moisés Selman, Annie Pardo
European Respiratory Journal (2021) Vol. 58, Iss. 3, pp. 2004507-2004507
Open Access | Times Cited: 60
Evaluation of Correlations between Genetic Variants and High-Resolution Computed Tomography Patterns in Idiopathic Pulmonary Fibrosis
Elisa Baratella, Barbara Ruaro, Fabiola Giudici, et al.
Diagnostics (2021) Vol. 11, Iss. 5, pp. 762-762
Open Access | Times Cited: 56
Research Progress in the Molecular Mechanisms, Therapeutic Targets, and Drug Development of Idiopathic Pulmonary Fibrosis
Hongbo Ma, Xuyi Wu, Yi Li, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 56
Lung Fibrosis and Fibrosis in the Lungs: Is It All about Myofibroblasts?
Elena Ortiz‐Zapater, Jaime Signes‐Costa, Paula Montero, et al.
Biomedicines (2022) Vol. 10, Iss. 6, pp. 1423-1423
Open Access | Times Cited: 55
Targeting Histone Deacetylases in Idiopathic Pulmonary Fibrosis: A Future Therapeutic Option
Martina Korfei, Poornima Mahavadi, Andreas Guenther
Cells (2022) Vol. 11, Iss. 10, pp. 1626-1626
Open Access | Times Cited: 45
Pirfenidone for Idiopathic Pulmonary Fibrosis and Beyond
Alberto Aimo, Giosafat Spitaleri, Dario Nieri, et al.
Cardiac failure review (2022) Vol. 8
Open Access | Times Cited: 42
Inhibition of antiapoptotic BCL-2 proteins with ABT-263 induces fibroblast apoptosis, reversing persistent pulmonary fibrosis
J. Cooley, N. Javkhlan, J. Wilson, et al.
JCI Insight (2023) Vol. 8, Iss. 3
Open Access | Times Cited: 32
Lipid nanoparticle-mediated mRNA delivery in lung fibrosis
Matteo Massaro, Suhong Wu, Gherardo Baudo, et al.
European Journal of Pharmaceutical Sciences (2023) Vol. 183, pp. 106370-106370
Open Access | Times Cited: 29
DNA sensing via the cGAS/STING pathway activates the immunoproteasome and adaptive T‐cell immunity
Xinyuan Wang, Huabin Zhang, Yuqin Wang, et al.
The EMBO Journal (2023) Vol. 42, Iss. 8
Open Access | Times Cited: 27
The role of macrophage polarization and cellular crosstalk in the pulmonary fibrotic microenvironment: a review
Bowen Zhou, Huaman Liu, Fei Xu, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 14
The Role of Cytokines and Molecular Pathways in Lung Fibrosis Following SARS-CoV-2 Infection: A Physiopathologic (Re)view
Mihai Lazăr, Mihai Săndulescu, Ecaterina Constanța Barbu, et al.
Biomedicines (2024) Vol. 12, Iss. 3, pp. 639-639
Open Access | Times Cited: 9
Pharmacological targeting of ECM homeostasis, fibroblast activation, and invasion for the treatment of pulmonary fibrosis
Ioannis Tomos, Paraskevi Kanellopoulou, Dimitris Nastos, et al.
Expert Opinion on Therapeutic Targets (2025)
Closed Access | Times Cited: 1
Fibrosis: cross-organ biology and pathways to development of innovative drugs
Florian Rieder, Laura E. Nagy, Toby M. Maher, et al.
Nature Reviews Drug Discovery (2025)
Closed Access | Times Cited: 1
ATF4 Mediates Mitochondrial Unfolded Protein Response in Alveolar Epithelial Cells
Dingyuan Jiang, Huachun Cui, Na Xie, et al.
American Journal of Respiratory Cell and Molecular Biology (2020) Vol. 63, Iss. 4, pp. 478-489
Open Access | Times Cited: 57
Epithelial–Mesenchymal Transition: A Major Pathogenic Driver in Idiopathic Pulmonary Fibrosis?
Francesco Salton, Barbara Ruaro, Paola Confalonieri, et al.
Medicina (2020) Vol. 56, Iss. 11, pp. 608-608
Open Access | Times Cited: 56
Pulmonary Stretch and Lung Mechanotransduction: Implications for Progression in the Fibrotic Lung
Alessandro Marchioni, Roberto Tonelli, Stefania Cerri, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6443-6443
Open Access | Times Cited: 52
Page 1 - Next Page

Scroll to top